Clinical trial
The VITALE Study Evaluating Safety and Effectiveness/Performance of the Microport CardioFlow VitaFlow II - Transcatheter Aortic Valve System
NCT03575039 is registered in ClinicalTrials.gov with Shanghai MicroPort CardioFlow Medtech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The VITALE Study Evaluating Safety and Effectiveness/Performance of the Microport CardioFlow VitaFlow II - Transcatheter Aortic Valve System
- Lead sponsor
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2018
- Completion date
- December 31, 2024
- Enrollment
- 178 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.